logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
V

Vivek Subbiah

stanford university school of medicine

78H指数
1.4K论文数
3.1W被引数
收录论文 258
发表时间
logo
The weight of the enemy: Tumor burden as a tumor-agnostic prognostic marker and the limits of immunotherapy肿瘤负担作为肿瘤非特异性预后标志物及其免疫治疗的局限性
errCancer
IF5.1
err2026-08-11
err0
PREAI
errVivek Subbiah MD; Elad Sharon MD, MPH
err分享
err收藏
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Knowledge Is PowerHER2突变非小细胞肺癌播客：知识就是力量
errTargeted Oncology
IF4
err2026-05-26
err0
errOAAI
errVivek Subbiah; Martin Dietrich; Xiuning Le
err分享
err收藏
HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding PatientsHER2突变非小细胞肺癌播客：寻找患者
errTargeted Oncology
IF4
err2026-05-13
err0
errOAAI
errVivek Subbiah; Martin Dietrich
err分享
err收藏
The Case for Tumour-Agnostic Reimbursement of Dual Immunotherapy肿瘤非依赖性双重免疫疗法报销的案例
errEuropean Journal of Cancer
IF7.1
err2026-05-05
err0
PREAI
errVivek Subbiah; Razelle Kurzrock
err分享
err收藏
Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective未知原发癌的分子引导精确肿瘤学: 最先进的观点
errJournal of Personalized Medicine
IF3
err2026-02-01
err0
errOAAI
errVivek Subbiah; Elie Rassy; Frank A. Greco
err分享
err收藏
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor PatientsIa/b期多中心研究：BPM31510IV单药治疗和联合化疗在实体瘤患者中靶向线粒体代谢/瓦伯格效应的应用
errCancer Research Communications
IF0
err2025-12-01
err0
errOAAI
errSubbiah, Vivek; Yu, Peter P.; Sarangarajan, Rangaprasad; Kiebish, Michael A.; Rodrigues, Leonardo O.; Miller, Gregory M.; Akmaev, Viatcheslav R.; Luan, Shen; McCook, John P.; Tanna, Nikunj; Reilly, Tracey; Chen, Emily; Bussberg, Valerie; Ravipaty, Shobha; Vishnudas, Vivek K.; Gesta, Stephane; Lucius, David; Bruce, Can; Hazarika, Suwagmani; Lyng, Arianne; Klotz, Allison; Tolstikov, Vladimir; Stevens, Janice; Chua, Victoria S.; Granger, Elder; Tekumalla, Poornima K.; Benaim, Ely; Modur, Vijay; Rudoltz, Marc S.; Song, Paul Y.; Tagawa, Scott T.; Hendifer, Andrew; Chawla, Sant P.; Shah, Manish A.; Hong, David S.; Zinner, Ralph; Narain, Niven R.; Kundranda, Madappa N.
err分享
err收藏
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors首次人体研究：一种钍-227标记的间皮素靶向抗体-螯合剂偶联物（MSLN-TTC）在恶性间皮瘤及其他实体瘤患者中的应用
errESMO Open
IF8.3
err2025-11-20
err0
errOAAI
errA. Minchom; O. Lindén; D.G. Knapen; R. Hassan; F.I. Lin; K. Jalkanen; V. Subbiah; A. Tafuri; D. Ferreira; V. Jardine; A. Cleton; J. Pinkert; F. Bladt; H. Hennekes; E.F. Smit
err分享
err收藏
Development of anti-cancer medicines in the current era当前时代抗癌药物的研发
errCANCER TREATMENT AND RESEARCH COMMUNICATIONS
IF0
err2025-09-01
err0
errOAAI
errMonk, Bradley J.; Patel, Manish R.; Toker, Sarper; Subbiah, Vivek; Gordan, Lucio N.
err分享
err收藏
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer分子肿瘤委员会：国际肺癌研究协会的共识声明
errJournal of Thoracic Oncology
IF20.8
err2025-07-07
err0
PREAI
errMihaela Aldea; Julia K. Rotow; Maria Arcila; Matthew Hatton; Lynette Sholl; Christian Rolfo; Marco Tagliamento; Teodora Radonic; Kurt A. Schalper; Vivek Subbiah; Umberto Malapelle; Anja C. Roden; Rami Manochakian; Ming-Sound Tsao; Helena Linardou; Rina Hui; Silvia Novello; Alastair Greystoke; Anjali Saqi; Sylvie Lantuejoul; David M. Hwang; Kelly Nevins; Murry Wynes; Saiama Waqar; Yuchen Han; Yasushi Yatabe; Wei-Chin Chang; Takuo Hayashi; Tae-Jung Kim; Paul Hofman; Fabio Tavora; Fred R. Hirsch; Valeria Denninghoff; Natasha B. Leighl; Alexander Drilon; Wendy A. Cooper; Sanja Dacic; Pranshu Mohindra; Nick Pavlakis; Fernando Lopez-Rios
err分享
err收藏
Bridging tumour classification and treatment连接肿瘤分类与治疗
errlancet oncology
IF0
err2025-06-30
err0
PREAI
errVivek Subbiah; Benedikt Westphalen; Guiseppe Curigliano; Fabrice Andre
err分享
err收藏
Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus晚期非小细胞肺癌的精准医学管理建议：专家共识
errFuture Oncology
IF2.6
err2025-06-27
err0
PREAI
errHampig Raphael Kourie; Mounir Ahmed Bachouchi; Malika Makhlouf Gamaz; Emad Anwar Dawoud; zine-Charaf Mohamed Amir; Hicham Abdelmalek El Attar; Samah Soud Alrehaily; Joseph Fadi Zouein; Nabih Naim; Ameer Dhahir Hameedi; Manwar Abdulelah Alnaqqash; Rami Abdel Rahim Mahfouz; Sarah Masri; Jamil Debs; Taoufiq Barrou; Hatem El Kadi; Vivek Subbiah; Frederique Penault-Llorca
err分享
err收藏
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis循环肿瘤DNA清除作为接受新辅助免疫检查点抑制剂治疗的实体瘤患者病理完全缓解的预测生物标志物：一项系统评价和荟萃分析
errAnnals of Oncology
IF65.4
err2025-04-03
err0
PREAI
errC. Valenza; E.F. Saldanha; Y. Gong; P. De Placido; D. Gritsch; H. Ortiz; D. Trapani; F. Conforti; C. Cremolini; S. Peters; J. Mateo; V. Subbiah; H.A. Parsons; A.H. Partridge; G. Curigliano
err分享
err收藏
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma选择性RET抑制剂治疗晚期遗传性甲状腺髓样癌的疗效和安全性
errTHYROID
IF6.7
err2025-01-01
err0
PREAI
errHamidi, Sarah; Yedururi, Sireesha; Hu, Mimi I.; Busaidy, Naifa L.; Sherman, Steven I.; Jimenez, Camilo; Grubbs, Elizabeth G.; Maniakas, Anastasios; Zafereo, Mark E.; Subbiah, Vivek; Waguespack, Steven G.
err分享
err收藏
Precision Oncology: A Global Perspective on Implementation and Policy Development
errJCO GLOBAL ONCOLOGY
IF3
err2025-01-01
err0
errOAAI
errHorgan, Denis; Tanner, Marcel; Aggarwal, Charu; Thomas, David; Grover, Surbhi; Basel-Salmon, Lina; Dienstmann, Rodrigo; Tan, Tira Jing Ying; Park, Woong-Yang; Abu Rasheed, Hadi Mohamad; Siu, Lillian L.; Ma, Brigette; Ortiz-Lopez, Rocio; van den Bulcke, Marc; Taucher, Silvia Castillo; Ferris, Andrea; Starling, Naureen; Malapelle, Umberto; Longshore, John; Saldana, Hugo Alberto Barrera; Subbiah, Vivek
err分享
err收藏
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein
errJOURNAL OF MEDICINAL CHEMISTRY
IF6.8
err2024-12-26
err0
PREAI
errWang, Yafeng; Hu, Xueqing; Pandey, Shriya; Khatri, Ujjwol; Shen, Tao; Subbiah, Vivek; Mooers, Blaine H. M.; Chao, Ting; Wang, Shaohui; Yu, Huaxuan; Sun, Xingmin; Wu, Jie; Cai, Jianfeng
err分享
err收藏
Leptomeningeal metastatic disease: new frontiers and future directions软脑膜转移性疾病: 新领域和未来方向
errNATURE REVIEWS CLINICAL ONCOLOGY
IF82.2
err2024-12-09
err0
PREAI
errOzair, Ahmad; Wilding, Hannah; Bhanja, Debarati; Mikolajewicz, Nicholas; Glantz, Michael; Grossman, Stuart A.; Sahgal, Arjun; Le Rhun, Emilie; Weller, Michael; Weiss, Tobias; Batchelor, Tracy T.; Wen, Patrick Y.; Haas-Kogan, Daphne A.; Khasraw, Mustafa; Ruda, Roberta; Soffietti, Riccardo; Vollmuth, Philipp; Subbiah, Vivek; Bettegowda, Chetan; Pham, Lily C.; Woodworth, Graeme F.; Ahluwalia, Manmeet S.; Mansouri, Alireza
err分享
err收藏
Redefining pancreatic cancer management with tumor-agnostic precision medicine用肿瘤不可知论的精准医学重新定义胰腺癌管理
errCARCINOGENESIS
IF2.9
err2024-11-08
err1
PREAI
errReddy, Neha K.; Subbiah, Vivek
err分享
err收藏
Optimizing Tomorrow's Drug Development with Project Optimus: Precision Dosing IS Precision Oncology用Optimus项目优化明天的药物开发: 精确剂量是精确的肿瘤学
errANNALS OF ONCOLOGY
IF65.4
err2024-10-01
err0
PREAI
errSubbiah, Vivek
err分享
err收藏
From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems
errCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
IF5.6
err2024-09-01
err3
PREAI
errHorgan, Denis; Pesapane, Filippo; van der Buckle, Marc; de Maria, Ruggero; Dube, France; Singh, Jaya; Lugowska, Iwona; Bayle, Arnaud; Hofman, Paul; Malapelle, Umberto; Hills, Tanya; Capoluongo, Ettore D.; Subbiah, Vivek
err分享
err收藏
Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis
errDIAGNOSTICS
IF3.3
err2024-08-28
err0
errOAAI
errKairemo, Kalevi; Macapinlac, Homer A.; Gouda, Mohammed; Subbiah, Vivek
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Gordon B. Mills
H 指数: 231 · 论文数: 3.5K
A
Anil K. Sood
H 指数: 174 · 论文数: 3.3K
P
P. Andrew Futreal
H 指数: 159 · 论文数: 1.3K
P
Philippe Moreau
H 指数: 159 · 论文数: 2.3K
J
Jean‐Yves Blay
H 指数: 158 · 论文数: 2.4K
查看更多